We use necessary cookies that allow our site to work. We also set optional cookies that help us improve our website. For more information about the types of cookies we use, visit our Cookies policy.

Cookie settings


Since 2001 Sanofi has a collaboration program with the WHO in an effort to combat sleeping sickness, leishmaniasis, Chagas disease, Buruli ulcer and yaws. The company has contributed to this partnership with drug donations (such as pentamidine, melarsoprol, eflornithine and today fexinidazole) for treating patients with sleeping sickness or Human African Trypanosomiasis (HAT), and financial support for the execution of programs of the Intensive Disease Management (IDM) department, to an amount of US$5 million per year.

Partner website

Become a partner

Whether you’re an individual or an organisation, there are ways you can join us and help to end neglected tropical diseases (NTDs).

Find out more